Expansion Opportunity Charter Research is expanding with a new Orlando location in early 2024, signaling growth momentum and a potential need for regional pilot studies, site coordination, and local partnerships to accelerate medication development.

Therapy Development Focus The company’s mission to develop new medications and therapies creates recurring demand for clinical research services, patient recruitment, trial management, and regulatory support across multiple therapeutic areas.

Industry Collaboration A recent partnership with Eli Lilly indicates openness to strategic collaborations and sponsor-led trials, presenting opportunities to position as a trusted CRO partner for late-stage or specialized studies.

Technology Stack Utilizes cloud and SaaS tools (Google Cloud, QuickBooks Online, Wix/Shopify, Mailchimp, UKG, 1Password, DigitalOcean) suggesting readiness for scalable operations, marketing automation, and secure data handling—worth highlighting compatibility with your tech-enabled trial workflows.

Financial Scale Revenue in the $10–25M range and 51–200 employees indicate a mid-market CRO profile with potential for mid-sized studies, multi-site execution, and need for optimized project management, cost controls, and scalable staffing solutions.